UFP Technologies reported a slight decrease in sales but an increase in net income for Q4 2019 compared to Q4 2018. Full year results showed significant growth in revenue, operating income, and net income, driven by increased medical sales and improved operating efficiency.
Net income for Q4 2019 was $5.8 million, or $0.77 per diluted share, compared to $4.4 million, or $0.59 per diluted share, in Q4 2018.
Sales for Q4 2019 were $50.3 million, slightly down from $50.7 million in Q4 2018.
Medical sales increased 16.9% to $128.9 million, representing 65% of the total business.
The company paid off the $56 million borrowed to purchase Dielectrics.
Analyze how earnings announcements historically affect stock price performance